Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Iowa doctor charged with 8 counts of manslaughter

By R&D Editors | September 5, 2012

A Des Moines doctor faces involuntary manslaughter charges for allegedly prescribing large amounts of narcotic painkillers to eight patients who fatally overdosed, including a metal band’s founder.

Dr. Daniel Baldi appeared Wednesday in Polk County District Court, and a judge entered a not guilty plea on his behalf, The Des Moines Register (http://dmreg.co/Q9pvXx ) reported. Involuntary manslaughter is an aggravated misdemeanor under Iowa law.

One of the eight patients was identified in court papers as Paul Gray, a founder of the band Slipknot. He died of an overdose in 2010 at an Urbandale hotel.

Court documents allege Baldi unintentionally caused Gray’s death by writing “high-dose prescription narcotics to a known drug addict” starting on Dec. 27, 2005.

Defense attorney Guy Cook said bringing criminal charges “is wrong” and Baldi would fight the charges.

“It is unprecedented to turn unfortunate deaths or medical results into a crime against a doctor,” Cook said in an email Wednesday to The Associated Press.

“Unexpected deaths can occur in sever, chronic pain patients unrelated to medical treatment. This is especially true with patients who are drug addicts or drug abusers,” Cook said.

Cook said five of the charges involved overdoses of admitted drug addicts, and two charges involved patients seen only once by Baldi.

The Register said Baldi faces four medical malpractice lawsuits, including three wrongful death suits. The three deaths in those lawsuits were among the eight cited in the criminal charges.

The Iowa Board of Medicine filed administrative charges against Baldi last month. The board alleges he prescribed large quantities of narcotics and other addictive drugs without properly assessing patients’ needs for the medications.

Baldi helped run an Iowa Health System treatment clinic in Des Moines, which closed at the end of June. Iowa Health officials have said they suspended Baldi from his job. They recently said that they no longer would comment about him, The Register said.

There is increasing national concern about abuse of narcotic painkillers and other prescription drugs.

The Iowa medical examiner’s office said last year that drug overdose deaths had jumped by more than 12 times over a decade. The office is seeing more than 100 such deaths per year, including many involving prescription medications. Some of them are suicides, but most are accidents, officials said.

___

Information from: The Des Moines Register, http://www.desmoinesregister.com

Related Articles Read More >

Parallel Bio’s embraces in-house drug development as FDA backs animal testing alternatives
R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
Life sciences M&A hit $240B in 2025 as Big Pharma preps for patent cliffs
Hansoh Bio signs 32,000-sq.-ft. lab lease at Research Square in Rockville, MD
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE